Company Filing History:
Years Active: 2021
Title: David Moser: Innovator in Pharmaceutical Chemistry
Introduction
David Moser is a notable inventor based in Milton Bridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have therapeutic applications.
Latest Patents
David Moser holds a patent for a compound titled "Dimethylaminoethanol salt of a GLP-1 receptor modulator - Crystalline 2-hydroxy-N,N-dimethylethanaminium 1-(2-(5-(tert-butyl)-thiophene-2-carboxamido)-3-(4-(5-(4'-ethyl-[1,1′-bi(cyclohexan)]-3-en-4-yl)pyrimidin-2-yl)phenyl)propanoyl)azetidine-3-carboxylate salt." This patent encompasses methods related to the synthesis and therapeutic use of the compound, showcasing his expertise in creating novel pharmaceutical agents.
Career Highlights
David Moser is currently employed at Receptos, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that address unmet medical needs, particularly in the realm of metabolic disorders.
Collaborations
David has collaborated with esteemed colleagues such as Ephraim Vidal and Roger Bakale. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David Moser is a prominent figure in the field of pharmaceutical innovation, with a patent that highlights his contributions to therapeutic chemistry. His ongoing work at Receptos, Inc. and collaborations with other experts further solidify his role as a key innovator in the industry.